A detailed history of Horrell Capital Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Horrell Capital Management, Inc. holds 70 shares of NVO stock, worth $6,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Previous 70 -0.0%
Holding current value
$6,049
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $7,147 - $9,514
70 New
70 $9,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Horrell Capital Management, Inc. Portfolio

Follow Horrell Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horrell Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Horrell Capital Management, Inc. with notifications on news.